Home Pharma Topics Regulatory Norms

Regulatory Norms

Distinguished industry leaders engage in a turnkey meeting to add fillip to India’s pre-eminent...

The exclusive, closed-door CEO Round Table belongs to the Stream of Leadership under the celebrated India Pharma Week umbrella In its second edition, the Round Table will cull the recommendations from elite thought leaders that will result in...

Quality Council of India, Government of India Approved & Certified Pharma Programmes in GMP,...

New Delhi, May 23, 2014 - Quality Council of India, Government of India has approved & certified Pharma Programmes in GMP, QA&QC and Regulatory Affairs. Under this approval, the diploma certificates for the post graduate & executive programmes...

Apex court allows petition seeking cancellation of Ranbaxy’s licence

New Delhi, March 15,2014: The Supreme Court on Friday issued notices to the Centre and Ranbaxy Laboratories on a petition seeking cancellation of the company’s licence and a CBI probe against it for allegedly supplying adulterated drugs in the...

Major reshuffle at drug controller’s office

Nine officials transferred recently; DCGI says move to bring transparency, accountability into the systemNew Delhi February 1st, 2014: - At a time when the Indian drug regulator is under a spotlight following international scrutiny of domestic pharmaceutical companies, the...

Regulatory Framework for Medical Education

 New Delhi December 18, 2013: In order to maintain the quality of regulatory framework in medical education, and also due to prevailing circumstances in the year 2010 involving the then President of Medical Council of India (MCI) in corruption...

Post Graduate and Executive Diploma in

 i) Good Manufacturing Practices ii) Quality Assurance and Quality Control iii) Regulatory Affairs & iv) Clinical Research (E/distance mode) For further details on GMP programmes VIEW , QA&QC...

DCGI has asked Indian drug maker, Sun Pharmaceuticals to halt their activities related to...

Mumbai November 18, 2013: Indian health regulator, the Drug Controller General of India, has asked Indian drug maker, Sun Pharmaceuticals to halt their activities related to clinical research at the company’s analytical laboratory in Mumbai. It...

USFDA approves Unichems generic hypertension tablets

Mumbai Nov 4,2013 : Unichem Laboratories announced the receipt of approval for its generic drug amlodipine besylate tablets by the United States Food and Drug Administration (USFDA). These amlodipine tablets are used in the treatment of hypertension and...

Rising global regulatory checks & warnings may tighten noose on India pharma: Eisai India...

New Delhi, September 30, 2013: The stringent regulations from international regulatory authorities of US and EU are tightening the noose around the Indian pharma industry. The increasing inspections are driven by the rising violations in manufacturing process, noted Sanjit...